10 October 2018

Equal access to and the affordability of innovative therapies remain a challenges across the EU. The MEPs Against Cancer interest group are hosting a special event to discuss a new White Paper from the Association of European Cancer Leagues (ECL) outlining how these disparities can and should be tackled.